Oxidations of N-(3-indoleethyl) cyclic aliphatic amines by horseradish peroxidase: The indole ring binds to the enzyme and mediates electron-transfer amine oxidation

Journal of the American Chemical Society

Volumn 130, Issue 3, 2008, Pages 933-944

  Ling, Ke Qing ^a   Li, Wen Shan ^a,b   Sayre, Lawrence M ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b INSTITUTE OF CHEMISTRY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTATIONAL DOCKING; CYCLIC ALIPHATIC AMINES; ELECTRON TRANSFER; ENZYME-SUBSTRATE COMPLEXATION;

CHARGE TRANSFER; COMPUTER SIMULATION; ENZYME ACTIVITY; OXIDATION; REACTION KINETICS;

AMINES;

ALIPHATIC AMINE; AMINE; HORSERADISH PEROXIDASE; INDOLE DERIVATIVE; N (3 INDOLEETHYL) CYCLIC ALIPHATIC AMINE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CHEMICAL REACTION KINETICS; DISSOCIATION CONSTANT; ELECTRON TRANSPORT; ELECTROSPRAY MASS SPECTROMETRY; ENZYME ACTIVITY; ENZYME SUBSTRATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MOLECULAR DOCKING; MOLECULAR DYNAMICS; OXIDATION;

AMINES; ELECTRON TRANSPORT; HORSERADISH PEROXIDASE; HYDROCARBONS, CYCLIC; HYDROGEN-ION CONCENTRATION; INDOLES; KINETICS; OXIDATION-REDUCTION; SUBSTRATE SPECIFICITY;

EID: 38349149323     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja075905s     Document Type: Article

References (56)

1. (a) Hersleth, H. P.; Ryde, U.; Rydberg, P.; Gorbitz, C. H.; Andersson, K. K. J. Inorg. Biochem. 2006, 100, 460-76.
2. (b) Behan, R. K.; Hoffart, L. M.; Stone, K. L.; Krebs, C.; Green, M. T. J. Am. Chem. Soc. 2006, 128, 11471-4.
3. (c) Harvey, J. N.; Bathelt, C. M.; Mulholland, A. J. J. Comput. Chem. 2006, 27, 1352-62.
4. (d) Green, M. T.; Dawson, J. H.; Gray, H. B. Science 2004, 304, 1653-6.
5. For recent reviews on the mechanisms of cytochrome P450 oxidations, see: (a) Isin, E. M.; Guengerich, F. P. Biochim. Biophys. Acta 2007, 1770, 314-29.
6. (b) Meunier, B.; de Visser, S. P.; Shaik, S. Chem. Rev. 2004, 104, 3947-80.
7. (c) Makris, T. M.; Davydov, R.; Denisov, I. G.; Hoffman, B. M.; Sligar, S. G. Drug Metab. Rev. 2002, 34, 691-708.
8. For recent reports on cytochrome P450 catalyzed amine oxidations, see: (d) Cerny, M. A.; Hanzlik, R. P. J. Am. Chem. Soc. 2006, 128, 3346-54.
9. (e) Jurva, U.; Bissel, P.; Isin, E. M.; Igarashi, K.; Kuttab, S.; Castagnoli, N., Jr. J. Am. Chem. Soc. 2005, 127, 12368-77.
10. (f) Shaffer, C. L.; Harriman, S.; Koen, Y. M.; Hanzlik, R. P. J. Am. Chem. Soc. 2002, 124, 8268-74.
11. (a) Griffin, B. W.; Davis, D. K.; Bruno, G. V. Bioorg. Chem. 1981, 10, 342-55.
12. (b) Van, der Zee, J.; Duling, D. R.; Mason, R. P.; Eling, T. E. J. Biol. Chem. 1989, 264, 19828-36.
13. (c) Shaffer, C. L.; Morton, M. D.; Hanzlik, R. P. J. Am. Chem. Soc. 2001, 123, 8502-8.
14. (d) Shaffer, C. L.; Morton, M. D.; Hanzlik, R. P. J. Am. Chem. Soc. 2001, 123, 349-50.
15. (a) Ator, M. A.; Ortiz de Montellano, P. R.; J. Biol. Chem. 1987, 262, 1542-51.
16. (b) Ortiz de Montellano, P. R.; Annu. Rev. Pharmacol. Toxicol. 1992, 32, 89-107.
17. (a) Dunford, H. B. In Peroxidases in Chemistry and Biology; Everse, J., Everse, K. E., Grisham, M. B., Eds.; CRC Press: Boca Raton, FL, 1991; Vol. 2, pp 1-24.
18. (b) Dunford, H. B. Heme Peroxidases; John Wiley & Sons, Inc.: New York, 1999.
19. Hayashi, Y.; Yamazaki, I. J. Biol. Chem. 1979, 254, 9101-6.
20. (a) Sasaki, J. C.; Fellers, R. S.; Colvin, M. E. Mutat. Res. 2002, 506-507, 79-89.
21. (b) Guengerich, F. P.; Yun, C. H.; Macdonald, T. L. J. Biol. Chem. 1996, 271, 27321-9.
22. (a) Fidy, J.; Paul, K.-G.; Vanderkooi, J. M. Biochemistry 1989, 28, 7531-41.
23. (b) Sukurada, J.; Takahashi, S.; Hosoya, T. J. Biol. Chem. 1986, 261, 9657-62.
24. Sayre, L. M.; Naismith, R. T., II; Bada, M. A.; Li, W.-S.; Klein, M. E.; Tennant, M. D. Biochim. Biophys. Acta 1996, 1296, 250-56.
25. Guengerich, P.; MacDonald, T. L. FASEB J. 1990, 4, 2453-9.
26. Wood, P. M. Biochem. Soc. Trans. 1992, 20, 349-52.
27. (a) Lindsay Smith, J. R.; Mead, L. A. V. J. Chem. Soc., Perkin Trans. 2 1973, 206-10.
28. (b) Lindsay Smith, J. R.; Masheder, D. J. Chem. Soc., Perkin Trans. 2 1976, 47-51.
29. (c) Lindsay Smith, J. R.; Masheder, D. J. Chem. Soc., Perkin Trans. 2 1977, 1732-6.
30. Li, W.-S. Ph.D. Thesis, Case Western Reserve University, Cleveland, OH, 1997.
31. (a) Elmarakby, S. A.; Duffel, M. W.; Goswami, A.; Sariaslani, F. S.; Rosazza, J. P. N. J. Med. Chem. 1989, 32, 674-9.
32. (b) Goswami, A.; Macdonald, T. L.; Hubbard, C.; Duffel, M. W.; Rosazza, J. P. N. Chem. Res. Toxicol. 1988, 1, 238-42.
33. Ling, K.-Q.; Sayre, L. M. Bioorg. Med. Chem. 2005, 13, 3543-51.
34. Ralston, I.; Dunford, H. B. Can. J. Biochem. 1978, 56, 1115-9.
35. Dunford, H. B.; Adeniran, A. J. Arch. Biochem. Biophys. 1986, 251, 536-42.
36. Job, D.; Dunford, H. B. Eur. J. Biochem. 1976, 66, 607-14.
37. (a) Silva, S. O.; Ximenes, V. F.; Catalani, L. H.; Campa, A. Biochem. Biophys. Res. Commun. 2000, 279, 657-62.
38. (b) Ximenes, V. F.; Catalani, L. H.; Campa, A. Biochem. Biophys. Res. Commun. 2001, 287, 130-4.
39. (c) Ximenes, V. F.; Campa, A.; Catalani, L. H. Arch. Biochem. Biophys. 2001, 387, 173-9.
40. (a) Skordos, K. W.; Skiles, G. K.; Laycock, J. D.; Lanza, D. L.; Yost, G. S. Chem. Res. Toxicol. 1998, 11, 741-9.
41. (b) Fennell, R. C. G.; Plant, S. G. P. J. Chem. Soc. 1932, 2872-6.
42. See for example: (a) Shirasaka, N.; Ohnishi, H.; Sato, K.; Miyamoto, R.; Terashita, T.; Yoshizumi, H. J. Biosci. Bioeng. 2005, 100, 653-6.
43. (b) Adam, W.; Lazarus, M.; Hoch, U.; Korb, M. N.; Saha-Moeller, C. R.; Schreier, P. J. Org. Chem. 1998, 63, 6123-7.
44. (c) Adam, W.; Hoch, U.; Lazarus, M.; Saha-Moeller, C. R.; Schreier, P. J. Am. Chem. Soc. 1995, 117, 11898-901.
45. Yeh, R.; Hemphill, D., Jr.; Sell, H. M. Biochemistry 1970, 9, 4229-32.
46. See for example, Wu, S.-P.; Liu, J.-F.; Jiang, Z.-Q. Chem. Commun. 1996, 493-4.
47. 19
48. For one example of kinetic saturation for HRP compound II reduction by p-cresol see: Critchlow, J. E.; Dunford, H. B. J. Biol. Chem. 1972, 247, 3703-13.
49. Krammer, A.; Kirchhoff, P. D.; Jiang, X.; Venkatachalam, C. M.; Waldman, M. J. Mol. Graphics Modell. 2005, 23, 395-407.
50. Berglund, G. I.; Carlsson, G. H.; Smith, A. T.; Szoke, H.; Henriksen, A.; Hajdu, J. Nature 2002, 417, 463-8.
51. Hallingback, H. R.; Gabdoulline, R. R.; Wade, R. C. Biochemistry 2006, 45, 2940-50.
52. Wang, F.; Sayre, L. M. J. Am. Chem. Soc. 1992, 114, 248-55.
53. Folkes, L. K.; Candeias, L. P. FEBS Lett. 1997, 412, 305-8.
54. Colosi, L. M.; Huang, Q.; Weber, W. J., Jr. J. Am. Chem. Soc. 2006, 128, 4041-7.
55. On the basis of the voltametrically measured redox potentials of 1-4 (Table 1) relative to the higher values of typical 3-alkylindoles (Waltman, R. J.; Diaz, A. F.; Bargon, J. J. Phys. Chem. 1984, 88, 4343-6), it might be predicted that oxidations of all four indoleethylamines would lead strictly to amine oxidation products. However, oxidation outcome also reflects the fact that it is the indole ring that is bound at the heme edge and is thus closest to the HRP oxidants.
56. Derat, E.; Shaik, S. J. Am. Chem. Soc. 2006, 128, 13940-9.